Kolexia
Durand-Zaleski Isabelle
Médecine générale
Hôpital Henri Mondor
Créteil, France
452 Activités
47 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Urgences Accident vasculaire cérébral Tumeurs du poumon Maladie des artères coronaires Carcinomes Infarctus du myocarde Infarctus COVID-19 Métastase tumorale

Industries

MARKET ACCESS TRANSFORMATION
118 collaboration(s)
Dernière en 2023
Health Advances
61 collaboration(s)
Dernière en 2023
BMS
22 collaboration(s)
Dernière en 2023
MSD
19 collaboration(s)
Dernière en 2023

Dernières activités

Weight telemonitoring of heart failure versus standard of care in a real-world setting: Results on mortality and hospitalizations in a 6-month nationwide matched cohort study.
European journal of heart failure   07 mars 2024
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer.
BMJ open   17 février 2024
Cost-effectiveness of stepwise provisional versus systematic dual stenting strategies in patients with distal bifurcation left main stem lesions: economic analysis of the EBC MAIN trial.
Open heart   19 janvier 2024
Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial-authors' reply.
The Lancet regional health. Europe   02 janvier 2024
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective.
American journal of cardiovascular drugs : drugs, devices, and other interventions   28 décembre 2023
Cost-effectiveness of modified diagnostic strategy to safely rule-out pulmonary embolism in the emergency department: a non-inferiority cluster crossover randomized trial (MODIGLIA-NI).
BMC emergency medicine   29 novembre 2023
Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study.
Clinical genitourinary cancer   24 novembre 2023
The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop.
International journal of technology assessment in health care   20 novembre 2023
QUALIOR: Study Evaluating the Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program, for Metastatic Cancer Patients Receiving Oral Targeted Therapy: The UNICANCER SdS 01 QUALIOR Study
Essai Clinique (Unicancer)   07 novembre 2023
MULTI-CAP: Combined Use of a Respiratory Broad Panel MULTIplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia: a Multicentre, Parallel-group, Open-label, Randomized Controlled Trial.
Essai Clinique (Assistance publique – Hôpitaux de Paris)   17 octobre 2023